#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Internal Medicine - Issue Suppl 3/2015

Leaders

3

Úvodní slovo prof. MUDr. Jaroslava Rybky, DrSc., nestora české diabetologie
Význam statistiky v programové péči o nemocné s diabetem

5

Medicine for the future: Clinical foundations firmly anchored through feedback from practice

Editorials

8

The National Health Care Information System of the Czech Republic will significantly enhance the information support of diabetology: editorial

Ladislav Dušek

Reviews

10

Realistic possibilities of using data sources in quality assessment of care of patients with diabetes in the Czech Republic: National Diabetes Information System

Milan Kvapil

Original Contributions

14

The mortality of patients with diabetes mellitus using oral antidiabetic drugs in the Czech Republic decreased over the decade of 2003–2013 and came closer to the population average

Jan Brož, Petr Honěk, Ladislav Dušek, Tomáš Pavlík, Milan Kvapil

21

Incidence of amputations among patients with diabetes mellitus in the Czech Republic from 2010 to 2014

Pavlína Piťhová, Petr Honěk, Ladislav Dušek, Tomáš Pavlík, Milan Kvapil

25

Analysis of the development of metformin and sulfonylurea prescriptions in the Czech Republic

Denisa Janíčková-Žďárská, Petr Honěk, Ladislav Dušek, Tomáš Pavlík, Milan Kvapil

30

Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data

Michaela Šnejdrlová, Richard Češka, Denisa Janíčková-Žďárská, Petr Honěk, Pavel Dušek, Tomáš Pavlík, Milan Kvapil

39

Monitoring of diabetes compensation in patients treated with an insulin pump in the Czech Republic

Zdeněk Rušavý, Petr Honěk, Ladislav Dušek, Tomáš Pavlík, Denisa Janíčková-Žďárská, Milan Kvapil

44

The PROROK project results after 6 months of intervention (Prospective observation project focusing on the relevance of the difference between fasting blood glucose levels and postprandial blood glucose for estimation of success of type 2 diabetes therapy)

Denisa Janíčková-Žďárská, Pavlína Piťhová, Tomáš Pavlík, Milan Kvapil

50

Clinical and economic benefits of the new antidiabetic drugs in the Czech Republic

Tomáš Doležal, Klára Kruntorádová

Internal Medicine

Issue Suppl 3

2015 Issue Suppl 3

Most read in this issue

#ADS_BOTTOM_SCRIPTS#